Quercegen Holdings

Quercegen Pharmaceuticals is a clinical-stage biotechnology company specializing in the research and development of quercetin-based compounds for therapeutic and nutritional applications. The company's primary focus is on its proprietary, highly purified form of quercetin known as QU995, which is utilized in clinical trials and high-end consumer products. Quercegen's research portfolio includes investigations into cardiovascular health, metabolic disorders, and broad-spectrum antiviral treatments, often in collaboration with academic and government institutions. Their work emphasizes the bioavailability and purity of flavonoids to achieve clinical-grade efficacy across multiple therapeutic areas.